Sentences with phrase «pharmacotherapy at»

Not exact matches

«It's concerning that we saw a higher rate of diagnosis of schizophrenia and seemingly an undertreatment in terms of pharmacotherapy for that group,» said Ashli A. Owen - Smith, co-author of the study and assistant professor of health management and policy in the School of Public Health at Georgia State University.

Some of these studies are aimed at studying the underlying mechanisms of drug abuse whereas others focus on potential pharmacotherapies.

Mads E. Jørgensen, M.B., of Gentofte Hospital, University of Copenhagen, Denmark and coauthors examined in - hospital records and out - of - hospital pharmacotherapy use in Danish patients with uncomplicated hypertension treated with at least two antihypertensive drugs (β - blockers, thiazides, calcium antagonists or renin - angiotensin system [RAS] inhibitors) undergoing noncardiac surgery between 2005 and 2011.

«We had hoped the new pharmacotherapy would help more people quit, but this is not what is happening,» said lead author Shu - Hong Zhu, PhD, a professor in the Department of Family Medicine and Public Health and director of Center for Research and Intervention in Tobacco Control at UC San Diego.

«Combination pharmacotherapy is becoming common in child and adolescent psychiatry, but there has been little research evaluating it,» said first author Michael Aman, director of clinical trials at Ohio State's Nisonger Center and emeritus professor of psychology.

Among adults motivated to quit smoking, 12 weeks of treatment with a nicotine patch, the drug varenicline, or combination nicotine replacement therapy produced no significant differences in confirmed rates of smoking abstinence at 26 or 52 weeks, raising questions about the current relative effectiveness of intense smoking cessation pharmacotherapies, according to a study in the January 26 issue of JAMA.

Dr. Innocenti is Associate Professor in the Division of Pharmacotherapy and Experimental Therapeutics of the UNC Eshelman School of Pharmacy at the University of North Carolina (UNC) at Chapel Hill.

Federico Innocenti, MD, PhD, is an Associate Professor in the Division of Pharmacotherapy and Experimental Therapeutics of the UNC Eshelman School of Pharmacy at the University of North Carolina (UNC) at Chapel Hill.

Thankfully, one of my girlfriends, Thy N. Le, Pharm.D., pharmacotherapy specialist and program director at the Brooklyn Hospital Center in New York and a mother, began the conversation early on with me about which skin care ingredients to avoid due to their potential teratogenic effects (birth defects).

Next Page: You can abuse them without being addicted [pagebreak] You can abuse them without being addicted The chance of addiction is statistically low, says Frank Vocci, PhD, director of the division of pharmacotherapy and the medical consequences of drug abuse at the National Institute on Drug Abuse.

The outpatient, Individual Transformation Program at the Kolp Institute is a treatment - oriented Food Addiction program utilizing ketamine - enhanced psycho - pharmacotherapy geared toward patients who are resistant to treatment with conventional pharmacotherapy and / or psychotherapy.

Relapse prevention pharmacotherapies are most effective at the «maintenance stage of change», that is, when patients are psychologically committed to changing addictive behaviour.

Previous studies have shown that CBT is more effective than minimal treatment controls, and at least comparable to pharmacotherapy.

This finding of the lack of impact on cognition is not surprising at one level as cognition is not targeted in either CBT or ST.. In fact there is surprisingly little evidence regarding the impact of psychotherapies or pharmacotherapy for depression on cognition, although the persistence of cognitive dysfunction despite improvement in depressive symptoms following treatment suggests that these most current treatments for depression are having little impact in this area (1).

The mean relapse rate is 50 % at one year and over 70 % at four years.1 A recent prospective twelve year follow - up study showed that individuals with bipolar disorder were symptomatic for 47 % of the time.2 This poor outcome in naturalistic settings suggests an efficacy effectiveness gap for mood stabilisers that has resulted in a re-assessment of the role of adjunctive psychological therapies in bipolar disorder.3 Recent randomised controlled trials show that the combination of pharmacotherapy and about 20 — 25 sessions of an evidence - based manualised therapy such as individual cognitive behaviour therapy4 or family focused therapy5 may reduce relapse rates in comparison to a control intervention (mainly treatment as usual) in currently euthymic people with bipolar disorder.